Stock Market & Financial Investment News

News Breaks March 13, 2013 08:11 EDT SURG Synergetics downgraded to Hold from Buy at Craig-Hallum Craig-Hallum downgraded Synergetics siting the weak Q2 report and lack of near-term visibility. Price target is $5.50. News For SURG From The Last 14 Days Check below for free stories on SURG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for SURG Sign up for a free trial to see the rest of the stories you've been missing.